Vaneck Biotech Etf Alpha and Beta Analysis

BBH Etf  USD 166.33  0.68  0.41%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as VanEck Biotech ETF. It also helps investors analyze the systematic and unsystematic risks associated with investing in VanEck Biotech over a specified time horizon. Remember, high VanEck Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to VanEck Biotech's market risk premium analysis include:
Beta
(0.16)
Alpha
0.077
Risk
0.96
Sharpe Ratio
0.0151
Expected Return
0.0144
Please note that although VanEck Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, VanEck Biotech did 0.08  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of VanEck Biotech ETF etf's relative risk over its benchmark. VanEck Biotech ETF has a beta of 0.16  . As returns on the market increase, returns on owning VanEck Biotech are expected to decrease at a much lower rate. During the bear market, VanEck Biotech is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out VanEck Biotech Backtesting, Portfolio Optimization, VanEck Biotech Correlation, VanEck Biotech Hype Analysis, VanEck Biotech Volatility, VanEck Biotech History and analyze VanEck Biotech Performance.

VanEck Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. VanEck Biotech market risk premium is the additional return an investor will receive from holding VanEck Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VanEck Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate VanEck Biotech's performance over market.
α0.08   β-0.16

VanEck Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of VanEck Biotech's Buy-and-hold return. Our buy-and-hold chart shows how VanEck Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

VanEck Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how VanEck Biotech etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VanEck Biotech shares will generate the highest return on investment. By understating and applying VanEck Biotech etf market price indicators, traders can identify VanEck Biotech position entry and exit signals to maximize returns.

VanEck Biotech Return and Market Media

The median price of VanEck Biotech for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 is 165.71 with a coefficient of variation of 1.48. The daily time series for the period is distributed with a sample standard deviation of 2.45, arithmetic mean of 165.34, and mean deviation of 1.89. The Etf received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Kestra Advisory Services LLC Raises Position in VanEck Biotech ETF - AmericanBankingNEWS
03/01/2024
2
Anchor Investment Management LLC Takes Position in VanEck Biotech ETF - Defense World
03/21/2024

About VanEck Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including VanEck or other etfs. Alpha measures the amount that position in VanEck Biotech ETF has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VanEck Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VanEck Biotech's short interest history, or implied volatility extrapolated from VanEck Biotech options trading.

Build Portfolio with VanEck Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out VanEck Biotech Backtesting, Portfolio Optimization, VanEck Biotech Correlation, VanEck Biotech Hype Analysis, VanEck Biotech Volatility, VanEck Biotech History and analyze VanEck Biotech Performance.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for VanEck Etf analysis

When running VanEck Biotech's price analysis, check to measure VanEck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VanEck Biotech is operating at the current time. Most of VanEck Biotech's value examination focuses on studying past and present price action to predict the probability of VanEck Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VanEck Biotech's price. Additionally, you may evaluate how the addition of VanEck Biotech to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
FinTech Suite
Use AI to screen and filter profitable investment opportunities
VanEck Biotech technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of VanEck Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of VanEck Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...